130 related articles for article (PubMed ID: 23868206)
1. Over-expression of regulator of G protein signaling 5 promotes tumor metastasis by inducing epithelial-mesenchymal transition in hepatocellular carcinoma cells.
Hu M; Chen X; Zhang J; Wang D; Fang X; Wang X; Wang G; Chen G; Jiang X; Xia H; Wang Y
J Surg Oncol; 2013 Sep; 108(3):192-6. PubMed ID: 23868206
[TBL] [Abstract][Full Text] [Related]
2. SIN1 promotes invasion and metastasis of hepatocellular carcinoma by facilitating epithelial-mesenchymal transition.
Xu J; Li X; Yang H; Chang R; Kong C; Yang L
Cancer; 2013 Jun; 119(12):2247-57. PubMed ID: 23564492
[TBL] [Abstract][Full Text] [Related]
3. Suppression of actopaxin impairs hepatocellular carcinoma metastasis through modulation of cell migration and invasion.
Ng L; Tung-Ping Poon R; Yau S; Chow A; Lam C; Li HS; Chung-Cheung Yau T; Law WL; Pang R
Hepatology; 2013 Aug; 58(2):667-79. PubMed ID: 23504997
[TBL] [Abstract][Full Text] [Related]
4. EDIL3 is a novel regulator of epithelial-mesenchymal transition controlling early recurrence of hepatocellular carcinoma.
Xia H; Chen J; Shi M; Gao H; Sekar K; Seshachalam VP; Ooi LL; Hui KM
J Hepatol; 2015 Oct; 63(4):863-73. PubMed ID: 25980764
[TBL] [Abstract][Full Text] [Related]
5. Tumor-derived secretory clusterin induces epithelial-mesenchymal transition and facilitates hepatocellular carcinoma metastasis.
Wang C; Jiang K; Kang X; Gao D; Sun C; Li Y; Sun L; Zhang S; Liu X; Wu W; Yang P; Guo K; Liu Y
Int J Biochem Cell Biol; 2012 Dec; 44(12):2308-20. PubMed ID: 23010347
[TBL] [Abstract][Full Text] [Related]
6. Block of proliferation 1 (BOP1) plays an oncogenic role in hepatocellular carcinoma by promoting epithelial-to-mesenchymal transition.
Chung KY; Cheng IK; Ching AK; Chu JH; Lai PB; Wong N
Hepatology; 2011 Jul; 54(1):307-18. PubMed ID: 21520196
[TBL] [Abstract][Full Text] [Related]
7. CtBP1 is involved in epithelial-mesenchymal transition and is a potential therapeutic target for hepatocellular carcinoma.
Zhang XL; Huang CX; Zhang J; Inoue A; Zeng SE; Xiao SJ
Oncol Rep; 2013 Aug; 30(2):809-14. PubMed ID: 23756565
[TBL] [Abstract][Full Text] [Related]
8. NEK2 promotes hepatocellular carcinoma migration and invasion through modulation of the epithelial-mesenchymal transition.
Zhang Y; Wang W; Wang Y; Huang X; Zhang Z; Chen B; Xie W; Li S; Shen S; Peng B
Oncol Rep; 2018 Mar; 39(3):1023-1033. PubMed ID: 29399700
[TBL] [Abstract][Full Text] [Related]
9. Expression of the serum response factor in hepatocellular carcinoma: implications for epithelial-mesenchymal transition.
Park MY; Kim KR; Park HS; Park BH; Choi HN; Jang KY; Chung MJ; Kang MJ; Lee DG; Moon WS
Int J Oncol; 2007 Dec; 31(6):1309-15. PubMed ID: 17982656
[TBL] [Abstract][Full Text] [Related]
10. Sorafenib down-regulates expression of HTATIP2 to promote invasiveness and metastasis of orthotopic hepatocellular carcinoma tumors in mice.
Zhang W; Sun HC; Wang WQ; Zhang QB; Zhuang PY; Xiong YQ; Zhu XD; Xu HX; Kong LQ; Wu WZ; Wang L; Song TQ; Li Q; Tang ZY
Gastroenterology; 2012 Dec; 143(6):1641-1649.e5. PubMed ID: 22922424
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of SIRT1 promotes metastasis through epithelial-mesenchymal transition in hepatocellular carcinoma.
Hao C; Zhu PX; Yang X; Han ZP; Jiang JH; Zong C; Zhang XG; Liu WT; Zhao QD; Fan TT; Zhang L; Wei LX
BMC Cancer; 2014 Dec; 14():978. PubMed ID: 25522783
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic activation of the MiR-200 family contributes to H19-mediated metastasis suppression in hepatocellular carcinoma.
Zhang L; Yang F; Yuan JH; Yuan SX; Zhou WP; Huo XS; Xu D; Bi HS; Wang F; Sun SH
Carcinogenesis; 2013 Mar; 34(3):577-86. PubMed ID: 23222811
[TBL] [Abstract][Full Text] [Related]
13. Reduced N-cadherin expression is associated with metastatic potential and poor surgical outcomes of hepatocellular carcinoma.
Zhan DQ; Wei S; Liu C; Liang BY; Ji GB; Chen XP; Xiong M; Huang ZY
J Gastroenterol Hepatol; 2012 Jan; 27(1):173-80. PubMed ID: 21777276
[TBL] [Abstract][Full Text] [Related]
14. Caveolin-1 overexpression is associated with hepatocellular carcinoma tumourigenesis and metastasis.
Tse EY; Ko FC; Tung EK; Chan LK; Lee TK; Ngan ES; Man K; Wong AS; Ng IO; Yam JW
J Pathol; 2012 Mar; 226(4):645-53. PubMed ID: 22072235
[TBL] [Abstract][Full Text] [Related]
15. Survivin-mediated cancer cell migration through GRP78 and epithelial-mesenchymal transition (EMT) marker expression in Mahlavu cells.
Tai CJ; Chin-Sheng H; Kuo LJ; Wei PL; Lu HH; Chen HA; Liu TZ; Liu JJ; Liu DZ; Ho YS; Wu CH; Chang YJ
Ann Surg Oncol; 2012 Jan; 19(1):336-43. PubMed ID: 21516372
[TBL] [Abstract][Full Text] [Related]
16. Protein tyrosine phosphatase receptor S acts as a metastatic suppressor in hepatocellular carcinoma by control of epithermal growth factor receptor-induced epithelial-mesenchymal transition.
Wang ZC; Gao Q; Shi JY; Guo WJ; Yang LX; Liu XY; Liu LZ; Ma LJ; Duan M; Zhao YJ; Wu YN; Gao DM; Wang XY; Shi GM; Ding ZB; Ke AW; Tang QQ; Cao Y; Zhou J; Fan J
Hepatology; 2015 Oct; 62(4):1201-14. PubMed ID: 25998839
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of CXCL5 mediates neutrophil infiltration and indicates poor prognosis for hepatocellular carcinoma.
Zhou SL; Dai Z; Zhou ZJ; Wang XY; Yang GH; Wang Z; Huang XW; Fan J; Zhou J
Hepatology; 2012 Dec; 56(6):2242-54. PubMed ID: 22711685
[TBL] [Abstract][Full Text] [Related]
18. TMPRSS4 promotes invasion, migration and metastasis of human tumor cells by facilitating an epithelial-mesenchymal transition.
Jung H; Lee KP; Park SJ; Park JH; Jang YS; Choi SY; Jung JG; Jo K; Park DY; Yoon JH; Park JH; Lim DS; Hong GR; Choi C; Park YK; Lee JW; Hong HJ; Kim S; Park YW
Oncogene; 2008 Apr; 27(18):2635-47. PubMed ID: 17968309
[TBL] [Abstract][Full Text] [Related]
19. [Expression of CXCR3 in hepatocellular carcinoma].
Shi M; Guo RP; Zhang CQ; Zhong C; Lin XJ; Li JQ
Ai Zheng; 2006 Oct; 25(10):1232-7. PubMed ID: 17059766
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of eukaryotic initiation factor 5A2 enhances cell motility and promotes tumor metastasis in hepatocellular carcinoma.
Tang DJ; Dong SS; Ma NF; Xie D; Chen L; Fu L; Lau SH; Li Y; Li Y; Guan XY
Hepatology; 2010 Apr; 51(4):1255-63. PubMed ID: 20112425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
